不同血漿代用品對(duì)大鼠血糖和電解質(zhì)影響的研究
[Abstract]:Objective to compare the effects of different plasma substitutes on blood glucose and electrolyte in rats. Methods male Wistar rats were randomly divided into 5 groups (10 rats per group). Succinyl gelatin (GEL), hydroxyethyl starch 200 (HES200), hydroxyethyl starch 130 (HES130) were used. Hydroxyethyl starch 40 (706) and dextran 40 (Dex40) were treated with severe acute isovolemic hemodilution (ANH),) at a dose of 94.76 mL / kg, respectively. Blood glucose and electrolyte concentration 1 hour after hemodilution and hemodilution. Results the concentrations of blood glucose, potassium ion and calcium ion (mmol/L) in artery and vein were 7.50 鹵0.50 vs6.87 鹵0.57, 3.72 鹵0.18 vs3.68 鹵0.21 (P0.05), 1.368 鹵0.039 vs1.289 鹵0.08 (P0.01), respectively. The concentrations of sodium ion and chloride ion (mmol/L) in artery and vein were 142.0 鹵1.4 vs 143.4 鹵1.7 (P0.01), respectively. 105.06 鹵2.26 vs106.08 鹵2.96 (P0.01). GEL and Dex40) significantly increased blood glucose concentration after hemodilution (P0.05 or 0.01). The concentration of blood glucose in HES130 and 706 groups increased significantly at 1 h of hemodilution (P0.05). The concentration of potassium ion in Dex40 group was significantly higher than that in other groups (P0.01). GEL,HES200, in Dex40 group was significantly higher than that in other groups (P0.01). After 1 hour of hemodilution, calcium concentration in HES130 and Dex40 groups increased significantly (P0.05 or 0.01). The concentration of chloride in GEL group was significantly lower than that in other groups (P0.01). Conclusion the rat model of ANH was induced by plasma substitute, the blood glucose and electrolyte were disturbed, and Dex40 caused abnormal increase of serum potassium after hemodilution.
【作者單位】: 軍事醫(yī)學(xué)科學(xué)院野戰(zhàn)輸血研究所;
【基金】:國(guó)家高技術(shù)研究發(fā)展計(jì)劃(“863”)(2012AA021902) 國(guó)家自然科學(xué)基金面上項(xiàng)目(31271001)
【分類(lèi)號(hào)】:R965
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李文碩;血漿代用品的臨床應(yīng)用[J];天津護(hù)理;2002年05期
2 葉穗雯;;血漿代用品的應(yīng)用現(xiàn)狀和研究進(jìn)展[J];中山大學(xué)學(xué)報(bào)論叢;2005年05期
3 林蓓;;血漿代用品在婦科圍術(shù)期的應(yīng)用[J];中國(guó)實(shí)用婦科與產(chǎn)科雜志;2007年03期
4 郭東勇;高魯渤;李錦成;;體外明膠類(lèi)血漿代用品對(duì)健康人體細(xì)胞因子的影響[J];中國(guó)煤炭工業(yè)醫(yī)學(xué)雜志;2007年02期
5 周忠英;胡忠杰;徐志紅;;血漿代用品的分類(lèi)和臨床應(yīng)用比較[J];全科醫(yī)學(xué)臨床與教育;2008年04期
6 劉士敬;;人工膠體血漿代用品的臨床應(yīng)用[J];中國(guó)社區(qū)醫(yī)師;2010年36期
7 孫嘉麟;施介生;;右旋醣酐——血漿代用品[J];中國(guó)藥學(xué)雜志;1958年02期
8 周北平;;血漿代用品的進(jìn)展[J];國(guó)外醫(yī)學(xué).生物制品分冊(cè);1979年03期
9 王秋生;;使用血漿代用品時(shí)應(yīng)特別注意副作用[J];國(guó)外醫(yī)學(xué).外科學(xué)分冊(cè);1987年03期
10 李佩珉 ,林文華,劉景和,崔翔,楊靜;新型血漿代用品在麻醉中治療低血容量的應(yīng)用(附110例分析)[J];福建醫(yī)藥雜志;2002年03期
相關(guān)重要報(bào)紙文章 前4條
1 楊六香;節(jié)約用血的“功臣”[N];中國(guó)醫(yī)藥報(bào);2003年
2 曉原;血漿代用品國(guó)內(nèi)市場(chǎng)[N];中國(guó)醫(yī)藥報(bào);2006年
3 記者 張春祥;環(huán)保血漿代用品問(wèn)世[N];牡丹江日?qǐng)?bào);2007年
4 楊六香;安全用血 節(jié)約用血[N];中國(guó)醫(yī)藥報(bào);2003年
相關(guān)碩士學(xué)位論文 前1條
1 李嶸立;海狗皮明膠血漿代用品的制備及分析方法研究[D];中國(guó)藥品生物制品檢定所;2005年
,本文編號(hào):2297682
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2297682.html